Keetia leucantha
Keetia leucantha · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Keetia leucantha is a plant species that has gained scientific interest due to its significant antiplasmodial activities. Researchers have focused on its leaf extracts, which contain vital bioactive chemicals such as oleanolic acid, ursolic acid, geranyl acetone, and phytol. These compounds demonstrate promising potential in combating serious parasitic infections, including malaria caused by Plasmodium falciparum. Furthermore, the plant shows efficacy against Leishmania mexicana mexicana, highlighting its medicinal versatility. This makes Keetia leucantha a subject of great importance in the ongoing search for new treatments for tropical diseases.
- Synonyms
- Plectronia Leucantha
- Common names
- Not available
- Family
- Rubiaceae
- Distribution
- Africa
- Plant Parts
- Leaf
Classification
Synonyms
Keetia leucantha is a botanical species that is sometimes identified by its synonym, Plectronia leucantha. This nomenclatural connection means that researchers may encounter both names when studying the plant's classification. While the names differ, they refer to the exact same biological entity within the botanical record. Understanding these synonyms is essential for maintaining accuracy in scientific documentation and field observations. Consequently, recognizing this relationship ensures that botanical data remains consistent across various academic resources.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Keetia leucantha is a fascinating specimen that belongs to the vast kingdom Plantae. Within this biological realm, the species is classified under the class Equisetopsida. It holds a specific place in the order Gentianales, showcasing its unique evolutionary lineage. Furthermore, this plant is a member of the Rubiaceae family, a group known for its diverse botanical characteristics. Ultimately, it is identified by its distinct placement within the genus Keetia.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Gentianales |
| Family | Rubiaceae |
| Genus | Keetia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Keetia leucantha is a plant species primarily found throughout the diverse landscapes of West Tropical Africa. Its natural distribution encompasses several key nations, including Benin and Burkina Faso. The species also thrives within the borders of Ghana and Guinea, showcasing its adaptability to the regional climate. Furthermore, its presence is well-documented across the Ivory Coast, cementing its role in the local ecosystem. This specific geographic range highlights the plant's significance within the West African botanical corridor.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Keetia leucantha possesses an obligatory climbing habit, meaning it relies entirely on external structures for support to reach the sunlight it needs to thrive.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Keetia leucantha has demonstrated significant antiplasmodial activity, making it a promising subject for the development of new malaria therapies. Through the use of NMR-based metabolic profiling, researchers have identified specific bioactive compounds within its twigs and leaves. The study revealed that this species possesses a higher concentration of triterpenoids and phenylpropanoid-conjugated triterpenes compared to other related plants. These specific phenylpropanoid-conjugated triterpenes were found to be highly correlated with the plant's ability to combat malaria parasites. Ultimately, the use of multivariate statistical models highlights the potential of Keetia leucantha as a rich natural source for discovering potent antiplasmodial drugs.
Compounds
Keetia leucantha is a West African tree traditionally utilized in medicine to combat various parasitic infections. Scientific analysis of its leaf extracts has revealed the presence of several bioactive compounds, including geranyl acetone and phytol. The plant is also rich in significant triterpenic acids such as oleanolic acid, ursolic acid, and betulinic acid. These specific constituents have demonstrated notable antitrypanosomal activity, particularly against the bloodstream forms of Trypanosoma brucei. Furthermore, many of these compounds act as inhibitors of the glycolytic enzyme GAPDH, providing a potential mechanism for the plant's medicinal efficacy.
Conditions
Keetia leucantha demonstrates significant medicinal potential through its ability to treat several parasitic infections. The plant's extracts and essential oils exhibit growth-inhibitory activities against Leishmania mexicana mexicana. Furthermore, Keetia leucantha is effective in treating Malaria by targeting Plasmodium falciparum. Research also confirms its efficacy in treating Trypanosoma brucei brucei. Specifically, the plant shows potent activity against the Trypanosoma brucei brucei bloodstream forms (Tbb BSF) of the parasite.
Preparations
Keetia leucantha is prepared as extracts from its twigs and leaves to facilitate chemical analysis. These botanical extracts are subjected to NMR-based metabolic profiling to identify specific antiplasmodial triterpenes. The resulting extracts allow researchers to use multivariate models to correlate chemical signals with biological activity. Through this process, the extracts of Keetia leucantha are shown to contain higher concentrations of triterpenoids compared to other species. Ultimately, the preparation of these extracts enables the detailed identification of bioactive metabolites responsible for malaria therapy potential.
Parts used
Keetia leucantha is a West African tree that has long been utilized in traditional medicine to combat various parasitic infections. Recent scientific investigations have focused heavily on the plant's leaves to identify bioactive compounds for drug development. Specifically, dichloromethane extracts of these leaves have demonstrated significant inhibitory activities against pathogens such as Plasmodium falciparum and Trypanosoma brucei. Through detailed chemical analysis, researchers identified several triterpenic acids and essential oils within the leaf components that possess potent antitrypanosomal properties. These findings highlight the therapeutic potential of Keetia leucantha leaves as a valuable source for discovering new antiplasmodial and antitrypanosomal treatments.